tirzepatide vial 2.5mg Zepbound Injection 2.5 mg/0.5 mL — Mountainside Medical Vial math- Help me understand

Syringe selection Use a U-100 insulin syringe

Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar in adults with type 2 diabetes

Longer term For ongoing use, review metabolic and kidney trends every 3-6 months with a clinician

Persistent, severe abdominal pain (which may radiate to the back) during treatment may indicate acute pancreatitis and warrants immediate discontinuation of the drug and medical attention

If your Mounjaro has been left out longer than 21 days or exposed to temperatures above 86F (30C), its safest to discard it

Ectopic and visceral fat reductions resulting from tirzepatide-induced weight reduction are posited to be particularly relevant to improvements in glycemic control and other cardiometabolic comorbidities and risk factors such as lipid levels and waist circumference [62]